[ sulge aken ]
| Elulookirjeldus (CV) | ||
| 1. | Eesnimi | Eduard |
| 2. | Perekonnanimi | Maron |
| 3. | Töökoht | Tartu Ülikooli psühhiaatriakliinik |
| 4. | Ametikoht | vanemteadur |
| 5. | Sünniaeg | 14.11.1975 (päev.kuu.aasta) |
| 6. | Haridus | kõrgem, Tartu Ülikool, arstiteaduskond, raviosakond |
| 7. | Teenistuskäik | 1993-1999 Tartu Ülikool, arstiteaduskond, raviosakond 1999-2000 Tartu Ülikool, internatuur 2000-2004 Tartu Ülikooli psühhiaatriakliinik, doktorant 2002-2003 Kuopio Ülikooli Haigla, nooremteadur 2003-2005 Tartu Ülikooli psühhiaatriakliinik, teadur 2004- Tartu Ülikooli psühhiaatriakliinik, resident 2005- Tartu Ülikooli psühhiaatriakliinik, vanemteadur |
| 8. | Teaduskraad | meditsiinidoktori kraad |
| 9. | Teaduskraadi välja andnud asutus, aasta |
Tartu Ülikool, 2004 |
| 10. | Tunnustused | European Certificate Course in Anxiety and Mood Disorders Finnish-Estonia Psychiatric Course The 2nd Maudsley Forum, a Course for European Psychiatrists Euroopa Neuropsühhofarmakoloogia Kolledži posteripreemia 2003, 2004; ECNP-ACNP exchange award 2004, Fellowship Award, 2005 Lundbeck Eesti AS uurimistöö preemia, 2001, 2003; Arstiteaduskonna päevade uurimistöö preemia, 2002. Kliinikumi doktoritöö preemia, 2004 World Federation of Societies of Biological Psychiatry- Lundbeck International Neuroscience Foundation Sponsorship Award 2005 |
| 11. | Teadusorganisatsiooniline ja –administratiivne tegevus |
Osavõtt erialastes seltsides Eesti Psühhiaatrite Seltsi liige, Eesti Bioloogilise Psühhiaatria Seltsi juhatuse liige, Maailma Bioloogilise Psühhiaatria Seltsi liige European College of Neuro-psychopharmacology liige |
| 12. | Juhendamisel kaitstud väitekirjad |
|
| 13. | Teadustöö põhisuunad | Peamised uurimisvaldkonnad on ärevushäirete epidemiolooga ja neurobioloogia, serotonini osatähtsus paanikahäires, ning psüühikahäirete geneetika. |
| 14. | Jooksvad grandid | |
| 15. | Teaduspublikatsioonid |
Tõru I, Shlik J, Maron E, Vasar V, Nutt DJ.Tryptophan depletion does not modify response to CCK-4 challenge in patients with panic disorder after treatment with citalopram. Psychopharmacology (Berl). 2006 May;186(1):107-12. Epub 2006 Mar 16. Koido K, Koks S, Nikopensius T, Maron E, Altmae S, Heinaste E, Vabrit K, Tammekivi V, Hallast P, Kurg A, Shlik J, Vasar V, Metspalu A, Vasar E. Polymorphisms in wolframin (WFS1) gene are possibly related to increased risk for mood disorders. Int J Neuropsychopharmacol. 2005 Jun;8(2):235-44. Epub 2004 Oct 11. PMID: 15473915 [PubMed - in process] Kõks S, Nikopensius T, Koido K, Maron E, Altmae S, Heinaste E, Vabrit K, Tammekivi V, Hallast P, Kurg A, Shlik J, Vasar V, Metspalu A, Vasar E. Analysis of SNP profiles in patients with major depressive disorder. Int J Neuropsychopharmacol. 2005 Jun 1;:1-8 [Epub ahead of print] PMID: 15927089 [PubMed - as supplied by publisher] Maron E, Lang A, Tasa G, Liivlaid L, Toru I, Must A, Vasar V, Shlik J. Associations between serotonin-related gene polymorphisms and panic disorder.Int J Neuropsychopharmacol. 2005 Jun;8(2):261-6. Epub 2005 Jan 26. PMID: 15670397 [PubMed - in process] Maron E, Nikopensius T, Koks S, Altmae S, Heinaste E, Vabrit K, Tammekivi V, Hallast P, Koido K, Kurg A, Metspalu A, Vasar E, Vasar V, Shlik J. Association study of 90 candidate gene polymorphisms in panic disorder. Psychiatr Genet. 2005 Mar;15(1):17-24. PMID: 15722953 [PubMed - in process] Maron E, Shlik J Serotonin function in panic disorder: important, but why? Neuropsychopharmacology 2005 Aug 31; [Epub ahead of print] PMID: 16132063 Maron E, Kuikka JT, Shlik J, Vasar V, Vanninen E, Tiihonen J. Reduced brain serotonin transporter binding in patients with panic disorder.Psychiatry Res. 2004 Dec 15;132(2):173-81. PMID: 15598551 [PubMed - indexed for MEDLINE] Maron E, Kuikka JT, Ulst K, Tiihonen J, Vasar V, Shlik J. SPECT imaging of serotonin transporter binding in patients with generalized anxiety disorder. Eur Arch Psychiatry Clin Neurosci. 2004 Dec;254(6):392-6. Epub 2004 Nov 12. PMID: 15538601 [PubMed - indexed for MEDLINE] Maron E, Tasa G, Toru I, Lang A, Vasar V, Shlik J. Association between serotonin-related genetic polymorphisms and CCK-4-induced panic attacks with or without 5-hydroxytryptophan pretreatment in healthy volunteers. World J Biol Psychiatry. 2004 Jul;5(3):149-54. PMID: 15346539 [PubMed - indexed for MEDLINE] Maron E, Toru I, Vasar V, Shlik J. The effect of 5-hydroxytryptophan on cholecystokinin-4-induced panic attacks in healthy volunteers. J Psychopharmacol. 2004 Jun;18(2):194-9. PMID: 15260907 [PubMed - indexed for MEDLINE] Shlik J, Maron E, Tru I, Aluoja A, Vasar V. Citalopram challenge in social anxiety disorder. Int J Neuropsychopharmacol. 2004 Jun;7(2):177-82. Epub 2004 Jan 23. PMID: 14741063 [PubMed - indexed for MEDLINE] |
viimati muudetud: 27.09.2005
| Curriculum Vitae (CV) | ||
| 1. | First Name | Eduard |
| 2. | Surname | Maron |
| 3. | Institution | University of Tartu, Department of Psychiatry |
| 4. | Position | senior research fellow |
| 5. | Date of birth | 14.11.1975 (day.month.year) |
| 6. | Education | higher, University of Tartu, Faculty of Medicine |
| 7. | Research and professional experience |
1993-1999 University of Tartu, Faculty of Medicine; 1999-2000 University of Tartu, internship; Diploma of physician (M.D.) 2000-2004 University of Tartu, Department of Psychiatry, doctoral student 2002-2003 Kuopio University Hospital, research associate 2003-2005 University of Tartu, Department of Psychiatry, research fellow 2004- University of Tartu, Department of Psychiatry, resident 2005- University of Tartu, Department of Psychiatry, senior research fellow |
| 8. | Academic degree | Doctor of Medical Sciences (Ph.D.) |
| 9. | Dates and sites of earning the degrees |
University of Tartu, 2004 |
| 10. | Honours/awards | European Certificate Course in Anxiety and Mood Disorders Finnish-Estonia Psychiatric Course The 2nd Maudsley Forum, a Course for European Psychiatrists European College of Neuropsychopharmacology Poster award 2003, 2004; ECNP-ACNP exchange award 2004; Fellowship Award, 2005 H.Lundbeck Estonia, Research award 2001, 2003; Conference of Medical Faculty, Research study award, 2002. Kliinikum award 2004 World Federation of Societies of Biological Psychiatry- Lundbeck International Neuroscience Foundation Sponsorship Award 2005 |
| 11. | Research-administrative experience |
Membership in professional organizations Estonian Association of Psychiatrists, Estonian Society of Biological Psychiatry, vice president World Federation of Societies of Biological Psychiatry European College of Neuropsychopharmacology. |
| 12. | Supervised dissertations | |
| 13. | Current research program | The main research areas include epidemiology and neurobiology of anxiety disorders, role of serotonin in panic disorder, and psychiatric genetics. |
| 14. | Current grant funding | |
| 15. | List of most important publications |
Tõru I, Shlik J, Maron E, Vasar V, Nutt DJ.Tryptophan depletion does not modify response to CCK-4 challenge in patients with panic disorder after treatment with citalopram. Psychopharmacology (Berl). 2006 May;186(1):107-12. Epub 2006 Mar 16. Koido K, Koks S, Nikopensius T, Maron E, Altmae S, Heinaste E, Vabrit K, Tammekivi V, Hallast P, Kurg A, Shlik J, Vasar V, Metspalu A, Vasar E. Polymorphisms in wolframin (WFS1) gene are possibly related to increased risk for mood disorders. Int J Neuropsychopharmacol. 2005 Jun;8(2):235-44. Epub 2004 Oct 11. PMID: 15473915 [PubMed - in process] Kõks S, Nikopensius T, Koido K, Maron E, Altmae S, Heinaste E, Vabrit K, Tammekivi V, Hallast P, Kurg A, Shlik J, Vasar V, Metspalu A, Vasar E. Analysis of SNP profiles in patients with major depressive disorder. Int J Neuropsychopharmacol. 2005 Jun 1;:1-8 [Epub ahead of print] PMID: 15927089 [PubMed - as supplied by publisher] Maron E, Lang A, Tasa G, Liivlaid L, Toru I, Must A, Vasar V, Shlik J. Associations between serotonin-related gene polymorphisms and panic disorder.Int J Neuropsychopharmacol. 2005 Jun;8(2):261-6. Epub 2005 Jan 26. PMID: 15670397 [PubMed - in process] Maron E, Nikopensius T, Koks S, Altmae S, Heinaste E, Vabrit K, Tammekivi V, Hallast P, Koido K, Kurg A, Metspalu A, Vasar E, Vasar V, Shlik J. Association study of 90 candidate gene polymorphisms in panic disorder. Psychiatr Genet. 2005 Mar;15(1):17-24. PMID: 15722953 [PubMed - in process] Maron E, Shlik J Serotonin function in panic disorder: important, but why? Neuropsychopharmacology 2005 Aug 31; [Epub ahead of print] PMID: 16132063 Maron E, Kuikka JT, Shlik J, Vasar V, Vanninen E, Tiihonen J. Reduced brain serotonin transporter binding in patients with panic disorder.Psychiatry Res. 2004 Dec 15;132(2):173-81. PMID: 15598551 [PubMed - indexed for MEDLINE] Maron E, Kuikka JT, Ulst K, Tiihonen J, Vasar V, Shlik J. SPECT imaging of serotonin transporter binding in patients with generalized anxiety disorder. Eur Arch Psychiatry Clin Neurosci. 2004 Dec;254(6):392-6. Epub 2004 Nov 12. PMID: 15538601 [PubMed - indexed for MEDLINE] Maron E, Tasa G, Toru I, Lang A, Vasar V, Shlik J. Association between serotonin-related genetic polymorphisms and CCK-4-induced panic attacks with or without 5-hydroxytryptophan pretreatment in healthy volunteers. World J Biol Psychiatry. 2004 Jul;5(3):149-54. PMID: 15346539 [PubMed - indexed for MEDLINE] Maron E, Toru I, Vasar V, Shlik J. The effect of 5-hydroxytryptophan on cholecystokinin-4-induced panic attacks in healthy volunteers. J Psychopharmacol. 2004 Jun;18(2):194-9. PMID: 15260907 [PubMed - indexed for MEDLINE] Shlik J, Maron E, Tru I, Aluoja A, Vasar V. Citalopram challenge in social anxiety disorder. Int J Neuropsychopharmacol. 2004 Jun;7(2):177-82. Epub 2004 Jan 23. PMID: 14741063 [PubMed - indexed for MEDLINE] |
last updated: 27.09.2005
[ sulge aken ]